Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Naltrexone and Acetaminophen in Acute Migraine
NCT03061734Phase 2Completed
- Sponsor
- Allodynic Therapeutics
- Start
- Feb 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in migraine, sponsored by Allodynic Therapeutics. Started Feb 2017; status: completed.
02
Drugs
naltrexone
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03061734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061734.